Clinical Trial Update: Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

This update summarizes a Phase 1 trial evaluating Velcade (bortezomib) in combination with ICE (ifosfamide, carboplatin, etoposide) for relapsed classical Hodgk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• Velcade (bortezomib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hodgkin Lymphoma, Lymphoma | Phase 1 | Status: COMPLETED